Bal Pharma Limited (BSE: 524824)
Health Care · Pharmaceuticals · IN
Rs93.15
-11.79% today · +11.6% 1Y
Bal Pharma Limited (BSE: 524824) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $15.32M.
Over the last twelve months the share price has gained 11.6%, trading between 59.69 and 124.68.
Tweenvest scores Bal Pharma Limited across four factors: quality 60/100, value 61/100, growth 3/100, dividend 28/100. Its strongest factor is value.
524824 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.32M
- Revenue (TTM)
- $35.37M
- P/E
- 20.69
- EPS
- 4.50
- Dividend yield
- 1.29%
- Beta (5Y)
- 0.44
- 52-week high
- Rs124.68
- 52-week low
- Rs59.69
- Avg volume (3M)
- —
- Shares outstanding
- 15.92M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kiora Pharmaceuticals, Inc.NasdaqCM: KPRX | $16.16M | $2.54 | -0.78% |
| Devonian Health Group Inc.TSXV: GSD | $16.08M | CA$8.25 | +3.13% |
| Peak Processing LimitedASX: PKP | $15.83M | AU$0.02 | +6.25% |
| Otsuka Pakistan LimitedKASE: OTSU | $15.72M | PKRs359.78 | +0.79% |
| Auro Laboratories LimitedBSE: 530233 | $15.24M | Rs236.60 | -2.95% |
| PeterLabs Holdings BerhadKLSE: PLABS | $15.16M | RM0.23 | +2.27% |
| Par Drugs and Chemicals LimitedNSEI: PAR | $14.89M | Rs117.10 | -5.53% |
| 1CM Inc.CNSX: EPIC | $14.85M | CA$0.18 | — |
Figures last refreshed Oct 11, 2026.